Series B Round
Funding Details
Hilo, formerly known as Aktiia, is a health tech company focused on managing global blood pressure levels through innovative technology and solutions. This Series B funding will fuel continued product innovation, expansion into new markets, and the build-out of its blood pressure intelligence platform. The company aims to enhance its cuffless blood pressure monitoring technology and broaden its global reach. The funding will also support strategic partnerships and collaborations to improve healthcare accessibility and patient outcomes. The round was led by Earlybird, with participation from Molten Ventures and other strategic investors, reflecting strong confidence in Hilo's vision to revolutionize blood pressure management.
Confidence Score
Participating Investors
Earlybird Health is a venture capital investor powering Europe's tech innovators with financial resources, strategic support, and access to a vast int...
Wellington Partners is a leading European venture capital firm that focuses on early- and growth-stage investments in life science companies, supporti...
Related Tweets
No tweets found for this funding round.